|
|
A synergistic effect on both drugs was observed on the upregulation of interleukin(IL)-10 mRNA,which was accompanied by an increase in IL-10 serum levels.Both in vitro and in vivo data suggest that a co-treatment of IFNbeta1b with PTX is a promising approach to correct the disturbed cytokine balance in MS patients. |
|